Novel antimicrobial agents for gram-negative pathogens

M Karvouniaris, MP Almyroudi, MH Abdul-Aziz, S Blot… - Antibiotics, 2023 - mdpi.com
Gram-negative bacterial resistance to antimicrobials has had an exponential increase at a
global level during the last decades and represent an everyday challenge, especially for the …

Tackling the Antimicrobial Resistance “Pandemic” with Machine Learning Tools: A Summary of Available Evidence

D Rusic, M Kumric, A Seselja Perisin, D Leskur, J Bukic… - Microorganisms, 2024 - mdpi.com
Antimicrobial resistance is recognised as one of the top threats healthcare is bound to face
in the future. There have been various attempts to preserve the efficacy of existing …

Prevalence of ST1049-KL5 carbapenem-resistant Klebsiella pneumoniae with a blaKPC-2 and blaNDM-1 co-carrying hypertransmissible IncM1 plasmid

H Liu, Y Xiang, M Xiong, X Xiao, J Zhou, H Tian… - Communications …, 2024 - nature.com
Infection caused by KPC and NDM carbapenemases co-producing Klebsiella pneumoniae
(KPC_NDM_CRKP) poses serious public health concerns. Here, we elucidate the …

Ceftazidime-avibactam combination therapy versus monotherapy for treating carbapenem-resistant gram-negative infection: a systemic review and meta-analysis

W Hsu, MH Chuang, WW Tsai, CC Lai, HY Lai… - Infection, 2024 - Springer
Background This meta-analysis was conducted to compare the efficacy of ceftazidime-
avibactam combination therapy with that of monotherapy in the treatment of carbapenem …

[HTML][HTML] Guidelines for Antibacterial Treatment of Carbapenem-Resistant Enterobacterales Infections

SY Park, YJ Baek, JH Kim, H Seong… - Infection & …, 2024 - pmc.ncbi.nlm.nih.gov
This guideline aims to promote the prudent use of antibacterial agents for managing
carbapenem-resistant Enterobacterales (CRE) infections in clinical practice in Korea. The …

Risk factors and prognostic model of carbapenem-resistant Klebsiella pneumoniae in patients with bloodstream infection

L Zeng, J Ma, J Qiu, Q Ren, C Wei, N Cheng - 2024 - researchsquare.com
Purpose Infections caused by Carbapenem-resistant Klebsiella pneumoniae (CRKP) are
increasing annually, with bloodstream infection (BSI) being a significant outcome associated …

Effectiveness of Ceftazidime/Avibactam treatment for infections caused by Klebsiella pneumoniae Carbapenemase (KPC), a 30-day mortality perspective. Comparison …

P Paschke, I Miczek, M Sambura… - Journal of Education …, 2024 - apcz.umk.pl
Abstract Introduction: Infections caused by Klebsiella pneumoniae carbapenemase (KPC)
pose a significant clinical challenge due to increasing antibiotic resistance. This study …

Actividad antimicrobiana del péptido palindrómico LfcinB (21-25) Pal RWQWRWQWR y sus análogos

AT Botina Rodríguez - repositorio.unal.edu.co
El incremento en la resistencia de los microorganismos a los tratamientos convencionales,
debido al uso indiscriminado de los antibióticos en humanos, animales y plantas, es un …

[引用][C] Prevalence of ST1049-KL5 carbapenem

H Liu, Y Xiang, M Xiong, X Xiao, J Zhou, H Tian…

[引用][C] 头孢他啶/阿维巴坦治疗耐碳青霉烯类肺炎克雷伯菌感染的研究进展

赵圆祺, 程明璟, 熊苗苗, 肖敏, 崔秀玉, 周子健… - 中国感染控制 …, 2024 - 中国感染控制杂志